SYNJ1 and Parkinsonism: Individuals affected by SYNJ1-associated parkinsonism generally show symptoms in the third decade of life, and manifest parkinsonism (tremor, bradykinesia) with a poor response to levodopa treatment, as well as additional atypical signs such as dystonia, seizures, cognitive impairment, and developmental delay [95].